Our Portfolio

Redefining Cancer Care With Tumor Responsive Nanomedicines

Our goal is to reinvigorate the treatment landscape for difficult-to-target tumors that are surrounded by dense stromal tissue. We mimic the self-assembly of DNA to create unprecedentedly small nanomedicines, each containing a duo of anti-cancer therapies, that can extravasate deep within tumors. Unique conditions within the tumor microenvironment cleave the environmentally sensitive bonds of our nanomedicines, releasing therapy directly in the tumor – exactly where it needs to be.